Biotechnology - Switzerland

Filter

Current filters:

Switzerland

Popular Filters

Roche acquires exclusive rights to AbVitro's extension-based target enrichment technology

Roche acquires exclusive rights to AbVitro's extension-based target enrichment technology

09-10-2014

Swiss drug major Roche has acquired exclusive rights to a primer extension-based target enrichment technology…

AbVitroBiotechnologyLicensingRocheSwitzerland

Celgene gains Swissmedic approval of Abraxane for both metastatic pancreatic and breast cancers

Celgene gains Swissmedic approval of Abraxane for both metastatic pancreatic and breast cancers

25-09-2014

Switzerland-based Celgene International, a wholly-owned subsidiary of US biotech major Celgene, say that…

AbraxaneBiotechnologyCelgene Corp.OncologyRegulationSwitzerland

Analysis of Roche’s InterMune acquisition

Analysis of Roche’s InterMune acquisition

28-08-2014

The acquisition of InterMune gives Swiss drug major Roche a substantial opportunity, owing to the Breakthrough…

BiotechnologyIdiopathic pulmonary fibrosisInterMuneMergers & AcquisitionspirfenidonePulmozymeRespiratory and PulmonaryRocheSwitzerlandXolair

Roche to partner with the Garvan Institute in genomics research

Roche to partner with the Garvan Institute in genomics research

20-08-2014

Swiss drug major Roche and the Garvan Institute of Medical Research are to collaborate in the development…

AustraliaBiotechnologyDNA sequencingGarvan InstituteGeneticsGenomics technologiesJohn MattickResearchRocheSwitzerland

Novartis makes investment in stem cell company Gamida Cell with option agreement

Novartis makes investment in stem cell company Gamida Cell with option agreement

19-08-2014

Swiss drug major Novartis has signed an investment and option agreement with Israeli stem cell specialist…

BiotechnologyFinancialGamida CellHematologyIsraelNovartisStem cell specialistSwitzerland

Roche to acquire Denmark’s Santaris Pharma

Roche to acquire Denmark’s Santaris Pharma

05-08-2014

Continuing on its path of strategic rather than mega transactions, Swiss pharma major Roche yesterday…

BiotechnologyMergers & AcquisitionsRocheSantaris PharmaSwitzerland

Harlan aims to provide expertise for biologics and biosimilars

31-07-2014

Switzerland-based Harlan Laboratories, a privately held provider of general and specialty toxicology…

BiosimilarsBiotechnologyContract research servicesHarlanRegulationResearchSwitzerlandToxicology services

New report finds upturn in the Swiss biotech sector in 2013

15-04-2014

The Swiss biotech sector saw increases in terms of net sales, capital investments and number of employees,…

BiotechnologyBusiness FinanceBusiness FinanceEnvironmentHelvetiiMarkets & MarketingNorthern EuropeSwitzerland

Back to top